메뉴 건너뛰기




Volumn 51, Issue 5, 2010, Pages 620-628

HIV-1 reverse transcriptase connection domain mutations: Dynamics of emergence and implications for success of combination antiretroviral therapy

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ANTIRETROVIRUS AGENT; DIDANOSINE; LAMIVUDINE; RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; THYMIDINE DERIVATIVE; VIRUS RNA; ZIDOVUDINE;

EID: 77955786296     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/655764     Document Type: Article
Times cited : (30)

References (39)
  • 1
    • 46349112103 scopus 로고    scopus 로고
    • Antiretroviral drug resistance testing in adult HIV-1 infection:Recommendations of an international aids society-usa panel
    • Hirsch MS, Gunthard HF, Schapiro JM, et al. Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel. Clin Infect Dis 2008; 47:266-285.
    • (2008) Clin Infect Dis , vol.2008 , Issue.47 , pp. 266-285
    • Hirsch, M.S.1    Gunthard, H.F.2    Schapiro, J.M.3
  • 2
    • 1442355578 scopus 로고    scopus 로고
    • HIV drug resistance
    • Clavel F, Hance AJ. HIV drug resistance. N Engl J Med 2004; 350:1023-1035.
    • (2004) N Engl J Med , vol.350 , pp. 1023-1035
    • Clavel, F.1    Hance, A.J.2
  • 3
    • 59849127268 scopus 로고    scopus 로고
    • Update of the drug resistance mutations in HIV-1
    • Johnson VA, Brun-Vezinet F, Clotet B, et al. Update of the drug resistance mutations in HIV-1. Top HIV Med 2008; 16:138-145.
    • (2008) Top HIV Med , vol.16 , pp. 138-145
    • Johnson, V.A.1    Brun-Vezinet, F.2    Clotet, B.3
  • 4
    • 0031925680 scopus 로고    scopus 로고
    • A novel polymorphism at codon 333 of human immunodeficiency virus type 1 reverse transcriptase can facilitate dual resistance to zidovudine and L-2',3'-dideoxy-3'-thiacytidine
    • Kemp SD, Shi C, Bloor S, Harrigan PR, Mellors JW, Larder BA. A novel polymorphism at codon 333 of human immunodeficiency virus type 1 reverse transcriptase can facilitate dual resistance to zidovudine and L-2',3'-dideoxy-3'-thiacytidine. J Virol 1998; 72:5093-5098.
    • (1998) J Virol , vol.72 , pp. 5093-5098
    • Kemp, S.D.1    Shi, C.2    Bloor, S.3    Harrigan, P.R.4    Mellors, J.W.5    Larder, B.A.6
  • 5
    • 13844312476 scopus 로고    scopus 로고
    • Mechanism for nucleoside analog-mediated abrogation of HIV-1 replication: Balance between RNase H activity and nucleotide excision
    • Nikolenko GN, Palmer S, Maldarelli F, Mellors JW, Coffin JM, Pathak VK. Mechanism for nucleoside analog-mediated abrogation of HIV-1 replication: balance between RNase H activity and nucleotide excision. Proc Natl Acad Sci U S A 2005; 102:2093-2098.
    • (2005) Proc Natl Acad Sci U S A , vol.102 , pp. 2093-2098
    • Nikolenko, G.N.1    Palmer, S.2    Maldarelli, F.3    Mellors, J.W.4    Coffin, J.M.5    Pathak, V.K.6
  • 6
    • 33846063300 scopus 로고    scopus 로고
    • Mutations in the connection domain of HIV-1 reverse transcriptase increase 3'- azido-3'-deoxythymidine resistance
    • Nikolenko GN, Delviks-Frankenberry KA, Palmer S, et al. Mutations in the connection domain of HIV-1 reverse transcriptase increase 3'- azido-3'deoxythymidine resistance. Proc Natl Acad Sci U S A 2007; 104:317-322.
    • (2007) Proc Natl Acad Sci U S A , vol.104 , pp. 317-322
    • Nikolenko, G.N.1    Delviks-Frankenberry, K.A.2    Palmer, S.3
  • 7
    • 34250811908 scopus 로고    scopus 로고
    • Mutations in human immunodeficiency virus type 1 RNase H primer grip enhance 3'-azido-3'-deoxythymidine resistance
    • Delviks-Frankenberry KA, Nikolenko GN, Barr R, Pathak VK. Mutations in human immunodeficiency virus type 1 RNase H primer grip enhance 3'-azido-3'-deoxythymidine resistance. J Virol 2007; 81:6837-6845.
    • (2007) J Virol , vol.81 , pp. 6837-6845
    • Delviks-Frankenberry, K.A.1    Nikolenko, G.N.2    Barr, R.3    Pathak, V.K.4
  • 8
    • 34547105526 scopus 로고    scopus 로고
    • Selection of mutations in the connection and RNase H domains of human immunodeficiency virus type 1 reverse transcriptase that increase resistance to 3'-azido-3'-dideoxythymidine
    • Brehm JH, Koontz D, Meteer JD, Pathak V, Sluis-Cremer N, Mellors JW. Selection of mutations in the connection and RNase H domains of human immunodeficiency virus type 1 reverse transcriptase that increase resistance to 3'-azido-3'-dideoxythymidine. J Virol 2007; 81: 7852-7859.
    • (2007) J Virol , vol.81 , pp. 7852-7859
    • Brehm, J.H.1    Koontz, D.2    Meteer, J.D.3    Pathak, V.4    Sluis-Cremer, N.5    Mellors, J.W.6
  • 9
    • 38049028352 scopus 로고    scopus 로고
    • N348I in the connection domain of HIV-1 reverse transcriptase confers zidovudine and nevirapine resistance
    • Yap SH, Sheen CW, Fahey J, et al. N348I in the connection domain of HIV-1 reverse transcriptase confers zidovudine and nevirapine resistance. PLoS Med 2007; 4:e335.
    • (2007) PLoS Med , vol.4
    • Yap, S.H.1    Sheen, C.W.2    Fahey, J.3
  • 10
    • 52049107430 scopus 로고    scopus 로고
    • Connection domain mutations N348I and A360V in HIV-1 reverse transcriptase enhance resistance to 3'-azido-3'-deoxythymidine through both RNase H-dependent and -independent mechanisms
    • Ehteshami M, Beilhartz GL, Scarth BJ, et al. Connection domain mutations N348I and A360V in HIV-1 reverse transcriptase enhance resistance to 3'-azido-3'-deoxythymidine through both RNase H-dependent and -independent mechanisms. J Biol Chem 2008; 283:22222-22232.
    • (2008) J Biol Chem , vol.283 , pp. 22222-22232
    • Ehteshami, M.1    Beilhartz, G.L.2    Scarth, B.J.3
  • 11
    • 59649106106 scopus 로고    scopus 로고
    • Effects of mutations in the connection and RNase H domains of HIV-1 reverse transcriptase on drug susceptibility
    • Ehteshami M, Gotte M. Effects of mutations in the connection and RNase H domains of HIV-1 reverse transcriptase on drug susceptibility. AIDS Rev 2008; 10:224-235.
    • (2008) AIDS Rev , vol.10 , pp. 224-235
    • Ehteshami, M.1    Gotte, M.2
  • 12
    • 33847018853 scopus 로고    scopus 로고
    • Identification of accessory mutations associated with high-level resistance in HIV-1 reverse transcriptase
    • Cane PA, Green H, Fearnhill E, Dunn D. Identification of accessory mutations associated with high-level resistance in HIV-1 reverse transcriptase. AIDS 2007; 21:447-455.
    • (2007) AIDS , vol.21 , pp. 447-455
    • Cane, P.A.1    Green, H.2    Fearnhill, E.3    Dunn, D.4
  • 13
    • 41149145592 scopus 로고    scopus 로고
    • Amino acid mutation N348I in the connection subdomain of human immunodeficiency virus type 1 reverse transcriptase confers multiclass resistance to nucleoside and nonnucleoside reverse transcriptase inhibitors
    • Hachiya A, Kodama EN, Sarafianos SG, et al. Amino acid mutation N348I in the connection subdomain of human immunodeficiency virus type 1 reverse transcriptase confers multiclass resistance to nucleoside and nonnucleoside reverse transcriptase inhibitors. J Virol 2008; 82:3261-3270.
    • (2008) J Virol , vol.82 , pp. 3261-3270
    • Hachiya, A.1    Kodama, E.N.2    Sarafianos, S.G.3
  • 14
    • 67149110355 scopus 로고    scopus 로고
    • Mutations in the thumb-connection and RNase H domain of HIV type-1 reverse transcriptase of antiretroviral treatment-experienced patients
    • Waters JM, O'Neal W, White KL, et al. Mutations in the thumb-connection and RNase H domain of HIV type-1 reverse transcriptase of antiretroviral treatment-experienced patients. Antivir Ther 2009; 14:231-239.
    • (2009) Antivir Ther , vol.14 , pp. 231-239
    • Waters, J.M.1    O'Neal, W.2    White, K.L.3
  • 15
    • 77950652922 scopus 로고    scopus 로고
    • Positive and negative drug selection pressures on the N348I connection domain mutation: New insights from in vivo data
    • Price H, Asboe D, Pozniak A, et al. Positive and negative drug selection pressures on the N348I connection domain mutation: new insights from in vivo data. Antivir Ther 2010; 15:203-211.
    • Antivir Ther , vol.2010 , Issue.15 , pp. 203-211
    • Price, H.1    Asboe, D.2    Pozniak, A.3
  • 16
    • 77749316883 scopus 로고    scopus 로고
    • Epidemiological and biological evidence for a compensatory effect of connection domain mutation N348I on M184V in HIV-1 reverse transcriptase
    • von Wyl V, Ehteshami M, Symons J, et al. Epidemiological and biological evidence for a compensatory effect of connection domain mutation N348I on M184V in HIV-1 reverse transcriptase. J Infect Dis 2010; 201:1054-1062.
    • J Infect Dis , vol.2010 , Issue.201 , pp. 1054-1062
    • Von Wyl, V.1    Ehteshami, M.2    Symons, J.3
  • 17
    • 64749091545 scopus 로고    scopus 로고
    • Clinical relevance of substitutions in the connection subdomain and RNase H domain of HIV- 1 reverse transcriptase from a cohort of antiretroviral treatment-naive patients
    • Hachiya A, Shimane K, Sarafianos SG, et al. Clinical relevance of substitutions in the connection subdomain and RNase H domain of HIV- 1 reverse transcriptase from a cohort of antiretroviral treatment-naive patients. Antiviral Res 2009; 82:115-121.
    • (2009) Antiviral Res , vol.82 , pp. 115-121
    • Hachiya, A.1    Shimane, K.2    Sarafianos, S.G.3
  • 18
    • 72249093641 scopus 로고    scopus 로고
    • Virologic failure of regimens containing two NRTIs plus efavirenz is not associated with the selection of mutations in the connection or RNase H domains of reverse transcriptase
    • Brehm J, Sheen CW, Hughes M, et al. Virologic failure of regimens containing two NRTIs plus efavirenz is not associated with the selection of mutations in the connection or RNase H domains of reverse transcriptase. Antivir Ther 2009; 14:A34.
    • (2009) Antivir Ther , vol.14
    • Brehm, J.1    Sheen, C.W.2    Hughes, M.3
  • 19
    • 77955812311 scopus 로고    scopus 로고
    • Mutation A376S in the RT connection domain is associated with an increased risk of virological failure to nevirapine-based therapy in NNRTI-naïve HIV-infected subjects in the EuroSIDA study
    • EuroSIDA Study Group, In:Program and abstracts of the 16th Conference on Retroviruses and Opportunistic Infections
    • Paredes RBW, Cozzi-Lepri A, Pou C, et al; EuroSIDA Study Group. Mutation A376S in the RT connection domain is associated with an increased risk of virological failure to nevirapine-based therapy in NNRTI-naïve HIV-infected subjects in the EuroSIDA study. In: Program and abstracts of the 16th Conference on Retroviruses and Opportunistic Infections. 2009. Abstract 646.
    • (2009) Abstract , vol.646
    • Paredes, R.B.W.1    Cozzi-Lepri, A.2    Pou, C.3
  • 20
    • 77953059719 scopus 로고    scopus 로고
    • Connection domain mutations in treatment-experienced patients in the OPTIMA trial
    • Dau B, Ayers D, Singer J, et al. Connection domain mutations in treatment-experienced patients in the OPTIMA trial. J Acquir Immune Defic Syndr 2010; 54:160-166.
    • J Acquir Immune Defic Syndr , vol.2010 , Issue.54 , pp. 160-166
    • Dau, B.1    Ayers, D.2    Singer, J.3
  • 21
    • 0035808017 scopus 로고    scopus 로고
    • Predictors of virologic and clinical outcomes in HIV-1-infected patients receiving concurrent treatment with indinavir, zidovudine, and lamivudine: AIDS clinical trials group protocol 320
    • Demeter LM, Hughes MD, Coombs RW, et al. Predictors of virologic and clinical outcomes in HIV-1-infected patients receiving concurrent treatment with indinavir, zidovudine, and lamivudine: AIDS Clinical Trials Group Protocol 320. Ann Intern Med 2001; 135:954-964.
    • (2001) Ann Intern Med , vol.135 , pp. 954-964
    • Demeter, L.M.1    Hughes, M.D.2    Coombs, R.W.3
  • 22
    • 0442268112 scopus 로고    scopus 로고
    • A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less
    • AIDS Clinical Trials Group 320 Study Team
    • Hammer SM, Squires KE, Hughes MD, et al; AIDS Clinical Trials Group 320 Study Team. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. N Engl J Med 1997; 337:725-733.
    • (1997) N Engl J Med , vol.337 , pp. 725-733
    • Hammer, S.M.1    Squires, K.E.2    Hughes, M.D.3
  • 23
    • 0033550965 scopus 로고    scopus 로고
    • Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: A prospective cohort study-Swiss HIV cohort study
    • Ledergerber B, Egger M, Opravil M, et al. Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study-Swiss HIV Cohort Study. Lancet 1999; 353:863-868.
    • (1999) Lancet , vol.353 , pp. 863-868
    • Ledergerber, B.1    Egger, M.2    Opravil, M.3
  • 24
    • 34548655652 scopus 로고    scopus 로고
    • Emergence of HIV-1 drug resistance in previously untreated patients initiating combination antiretroviral treatment: A comparison of different regimen types
    • von Wyl V, Yerly S, Boni J, et al. Emergence of HIV-1 drug resistance in previously untreated patients initiating combination antiretroviral treatment: a comparison of different regimen types. Arch Intern Med 2007; 167:1782-1790.
    • (2007) Arch Intern Med , vol.167 , pp. 1782-1790
    • Von Wyl, V.1    Yerly, S.2    Boni, J.3
  • 25
    • 0030818643 scopus 로고    scopus 로고
    • Lamivudine-resistant human immunodeficiency virus type 1 variants (184V) require multiple amino acid changes to become co-resistant to zidovudine in vivo
    • Nijhuis M, Schuurman R, de Jong D, et al. Lamivudine-resistant human immunodeficiency virus type 1 variants (184V) require multiple amino acid changes to become co-resistant to zidovudine in vivo. J Infect Dis 1997; 176:398-405.
    • (1997) J Infect Dis , vol.176 , pp. 398-405
    • Nijhuis, M.1    Schuurman, R.2    De Jong, D.3
  • 26
    • 73649114589 scopus 로고    scopus 로고
    • The impact of the 0-0 cell on measures of amino acid covariation
    • Dunn D, von Wyl V, Price H, Asboe D. The impact of the 0-0 cell on measures of amino acid covariation. AIDS 2010; 24:159-160.
    • AIDS , vol.2010 , Issue.24 , pp. 159-160
    • Dunn, D.1    Von Wyl, V.2    Price, H.3    Asboe, D.4
  • 27
    • 33745781478 scopus 로고    scopus 로고
    • Involvement of novel human immunodeficiency virus type 1 reverse transcriptase mutations in the regulation of resistance to nucleoside inhibitors
    • Svicher V, Sing T, Santoro MM, et al. Involvement of novel human immunodeficiency virus type 1 reverse transcriptase mutations in the regulation of resistance to nucleoside inhibitors. J Virol 2006; 80:7186-7198.
    • (2006) J Virol , vol.80 , pp. 7186-7198
    • Svicher, V.1    Sing, T.2    Santoro, M.M.3
  • 28
    • 33845353741 scopus 로고    scopus 로고
    • Analysis of HIV-1 pol sequences using Bayesian networks: Implications for drug resistance
    • Deforche K, Silander T, Camacho R, et al. Analysis of HIV-1 pol sequences using Bayesian networks: implications for drug resistance. Bioinformatics 2006; 22:2975-2979.
    • (2006) Bioinformatics , vol.22 , pp. 2975-2979
    • Deforche, K.1    Silander, T.2    Camacho, R.3
  • 29
    • 48949097660 scopus 로고    scopus 로고
    • Antiretroviral treatment of adult HIV infection: Recommendations of the international aids society- USA panel
    • Hammer SM, Eron JJ Jr, Reiss P, et al. Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society- USA panel. JAMA 2008; 300:555-570.
    • (2008) JAMA , vol.300 , pp. 555-570
    • Hammer, S.M.1    Eron Jr., J.J.2    Reiss, P.3
  • 30
    • 0033570279 scopus 로고    scopus 로고
    • Analysis of binary outcomes in longitudinal studies using weighted estimating equations and discrete- time survival methods: prevalence and incidence of smoking in an adolescent cohort
    • Carlin JB, Wolfe R, Coffey C, Patton GC. Analysis of binary outcomes in longitudinal studies using weighted estimating equations and discrete- time survival methods: prevalence and incidence of smoking in an adolescent cohort. Stat Med 1999; 18:2655-2679.
    • (1999) Stat Med , vol.18 , pp. 2655-2679
    • Carlin, J.B.1    Wolfe, R.2    Coffey, C.3    Patton, G.C.4
  • 33
    • 0001677717 scopus 로고
    • Controlling the false discovery rate-A practical and powerful approach to multiple testing
    • Benjamini Y, Hochberg Y. Controlling the false discovery rate-a practical and powerful approach to multiple testing. J Roy Stat Soc B 1995; 57:289-300.
    • (1995) J Roy Stat Soc B , vol.57 , pp. 289-300
    • Benjamini, Y.1    Hochberg, Y.2
  • 34
    • 34249660534 scopus 로고    scopus 로고
    • HIV-1 subtype B protease and reverse transcriptase amino acid covariation
    • Rhee SY, Liu TF, Holmes SP, Shafer RW. HIV-1 subtype B protease and reverse transcriptase amino acid covariation. PLoS Comput Biol 2007; 3:e87.
    • (2007) PLoS Comput Biol , vol.3
    • Rhee, S.Y.1    Liu, T.F.2    Holmes, S.P.3    Shafer, R.W.4
  • 35
    • 0345306634 scopus 로고    scopus 로고
    • Thymidine analogue reverse transcriptase inhibitors resistance mutations profiles and association to other nucleoside reverse transcriptase inhibitors resistance mutations observed in the context of virological failure
    • Marcelin AG, Delaugerre C, Wirden M, et al. Thymidine analogue reverse transcriptase inhibitors resistance mutations profiles and association to other nucleoside reverse transcriptase inhibitors resistance mutations observed in the context of virological failure. J Med Virol 2004; 72:162-165.
    • (2004) J Med Virol , vol.72 , pp. 162-165
    • Marcelin, A.G.1    Delaugerre, C.2    Wirden, M.3
  • 36
    • 0032701542 scopus 로고    scopus 로고
    • Mutation patterns of the reverse transcriptase and protease genes in human immunodeficiency virus type 1-infected patients undergoing combination therapy: Survey of 787 sequences
    • Yahi N, Tamalet C, Tourres C, et al. Mutation patterns of the reverse transcriptase and protease genes in human immunodeficiency virus type 1-infected patients undergoing combination therapy: survey of 787 sequences. J Clin Microbiol 1999; 37:4099-4106.
    • (1999) J Clin Microbiol , vol.37 , pp. 4099-4106
    • Yahi, N.1    Tamalet, C.2    Tourres, C.3
  • 37
    • 38049007454 scopus 로고    scopus 로고
    • Should we include connection domain mutations of HIV-1 reverse transcriptase in HIV resistance testing
    • Gotte M. Should we include connection domain mutations of HIV-1 reverse transcriptase in HIV resistance testing. PLoS Med 2007; 4:e346.
    • (2007) PLoS Med , vol.4
    • Gotte, M.1
  • 38
    • 42149146684 scopus 로고    scopus 로고
    • The involvement of HIV-1 RNAse H in resistance to nucleoside analogues
    • Roquebert B, Marcelin AG. The involvement of HIV-1 RNAse H in resistance to nucleoside analogues. J Antimicrob Chemother 2008; 61: 973-975.
    • (2008) J Antimicrob Chemother , vol.61 , pp. 973-975
    • Roquebert, B.1    Marcelin, A.G.2
  • 39
    • 77955829413 scopus 로고    scopus 로고
    • Prevalence and in vitro characteristics of reverse transcriptase (RT) N348I mutation in non b subtypes in the absence of viral load monitoring in the DART study (NORA substudy)
    • DART Virology Group,In:Program and abstracts of the 16th Conference on Retroviruses and Opportunistic Infections.
    • McCormick ABA, Katundu P, Lyagoba F, et al; DART Virology Group. Prevalence and in vitro characteristics of reverse transcriptase (RT) N348I mutation in non b subtypes, in the absence of viral load monitoring, in the DART study (NORA substudy). In: Program and abstracts of the 16th Conference on Retroviruses and Opportunistic Infections. 2009. Abstract 643.
    • (2009) Abstract , vol.643
    • McCormick, A.B.A.1    Katundu, P.2    Lyagoba, F.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.